Clinical Trial Update: A Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese or Overweight Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial assessing drug–drug interactions of HRS-7535 with acetaminophen, digoxin, rosuvastatin, and omeprazole in overweight or obese adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Acetaminophen (Acetaminophen)
• DIGOXIN (Digoxin)
• HRS-7535 (HRS-7535)
• Omeprazole (Omeprazole)
• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Obesity, Overweight | Phase 1 | Status: COMPLETED